Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fitch

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
The Journal of Allergy and Clinical Immunology|February 16, 2017
Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiotaAmanda J McFarlane, Henry J McSorley, Donald J Davidson, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2016
Filaggrin-null mutations are associated with increased maturation markers on Langerhans cellsClaire S Leitch, Eenass Natafji, Cunjing Yu, et al.
Thrombosis and Haemostasis|May 5, 2007
A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog modelsYi-Xin Wang, Jon Vincelette, Valdeci da Cunha, et al.
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Substituted benzothiadizine inhibitors of Hepatitis C virus polymeraseAntony N Shaw, Rosanna Tedesco, Ramesh Bambal, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 22, 1998
Phylogenetic analysis of the nef gene reveals a distinctive monophyletic clade in Korean HIV-1 casesM R Kang, Y K Cho, J Chun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2021
The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviewsR J Chan, M Crichton, F Crawford-Williams, et al.
Journal of Medicinal Chemistry|February 3, 2006
3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymeraseRosanna Tedesco, Antony N Shaw, Ramesh Bambal, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 17, 2025
Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013R S Gill, S Apte, S Majumdar, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Allergy and Clinical Immunology|February 16, 2017
Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiotaAmanda J McFarlane, Henry J McSorley, Donald J Davidson, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2016
Filaggrin-null mutations are associated with increased maturation markers on Langerhans cellsClaire S Leitch, Eenass Natafji, Cunjing Yu, et al.
Thrombosis and Haemostasis|May 5, 2007
A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog modelsYi-Xin Wang, Jon Vincelette, Valdeci da Cunha, et al.
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Substituted benzothiadizine inhibitors of Hepatitis C virus polymeraseAntony N Shaw, Rosanna Tedesco, Ramesh Bambal, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 22, 1998
Phylogenetic analysis of the nef gene reveals a distinctive monophyletic clade in Korean HIV-1 casesM R Kang, Y K Cho, J Chun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2021
The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviewsR J Chan, M Crichton, F Crawford-Williams, et al.
Journal of Medicinal Chemistry|February 3, 2006
3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymeraseRosanna Tedesco, Antony N Shaw, Ramesh Bambal, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 17, 2025
Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013R S Gill, S Apte, S Majumdar, et al.
Pageof 32